Nozoe Tadahiro, Nozoe Emiko, Kono Mayuko, Ohga Takefumi, Ezaki Takahiro
Department of Surgery, Fukuoka Higashi Medical Center.
Department of Breast Surgery, Saiseikai Fukuoka General Hospital.
J Med Invest. 2017;64(3.4):241-244. doi: 10.2152/jmi.64.241.
Serum appearance of anti-p53 antibody (p53Ab) has been reported as an indicator for progressive potential of human tumor tumors including breast cancer. But its significance in breast cancer has not been discussed fully.
Relationship between serum appearance of p53Abs and representative data accounting for progressive potential in breast cancer, nuclear grade (NG), triple negative cancer, and the cumulative score based on these two data (TGS) was investigated among 129 women with invasive ductal carcinoma (IDC) of the breast, who had been treated with surgical resection.
There was a significant correlation between appearance of p53Abs and recurrence of the tumors (P = 0.035). Significant correlation of serum appearance of p53Abs with negative expression of ER (P = 0.011), the proportion of TNBC (P = 0.013), NG (P = 0.017), and TGS (P = 0.0005).
Preoperative serum appearance of p53Abs can be correlated with pathological nuclear grade, incidence of triple negative breast cancer, and TGS. These results might demonstrate more powerful significance of serum appearance of p53Abs as an indicator of progressive potential in IDC of the breast. J. Med. Invest. 64: 241-244, August, 2017.
抗p53抗体(p53Ab)的血清学表现已被报道为包括乳腺癌在内的人类肿瘤进展潜能的一个指标。但其在乳腺癌中的意义尚未得到充分讨论。
在129例接受手术切除治疗的乳腺浸润性导管癌(IDC)女性患者中,研究了p53Abs的血清学表现与代表乳腺癌进展潜能的代表性数据、核分级(NG)、三阴性癌以及基于这两个数据的累积评分(TGS)之间的关系。
p53Abs的出现与肿瘤复发之间存在显著相关性(P = 0.035)。p53Abs的血清学表现与ER阴性表达(P = 0.011)、三阴性乳腺癌的比例(P = 0.013)、NG(P = 0.017)和TGS(P = 0.0005)之间存在显著相关性。
术前血清中p53Abs的出现可能与病理核分级、三阴性乳腺癌的发生率和TGS相关。这些结果可能表明p53Abs的血清学表现作为乳腺IDC进展潜能指标具有更强的意义。《医学调查杂志》64: 241 - 244,2017年8月。